GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: BMS-986397 | BMS986397 | CC-91633 [3] | CC91633 | compound 173 [WO2020243379] | example 25 [WO2020243379]
Compound class:
Synthetic organic
Comment: The chemical structure for this compound was obtained from WHO INN proposed list 134 (Feb 2026), in which it is described as a serine/threonine kinase degradation inducer with antineoplastic potential. A structure search in PubChem suggests that this is the INN for BMS-986397, a lead casein kinase 1α (CK1α) degrader [2]. Claimed in Celgene Corp. patent WO2020243379A1 [1]. Relzasertideg targets CK1α for CRL4CRBN E3 ubiquitin ligase-mediated degradation.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Ligand families/groups | PROTACs, molecular glues and other degraders |
IUPAC Name ![]() |
| N-[(1R)-1-(3-chloro-2-pyridinyl)-2,2,2-trifluoroethyl]-2-[(3S)-2,6-dioxopiperidin-3-yl]-1-oxo-3H-isoindole-5-carboxamide |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 13983 | relzasertideg |
Synonyms ![]() |
|
| BMS-986397 | BMS986397 | CC-91633 [3] | CC91633 | compound 173 [WO2020243379] | example 25 [WO2020243379] | |
Database Links ![]() |
|
| Search Google for chemical match using the InChIKey | DGAWFEDONPXNNP-WMLDXEAASA-N |
| Search Google for chemicals with the same backbone | DGAWFEDONPXNNP |
| Search PubMed clinical trials | relzasertideg |
| Search PubMed titles | relzasertideg |
| Search PubMed titles/abstracts | relzasertideg |
| UniChem Compound Search for chemical match using the InChIKey | DGAWFEDONPXNNP-WMLDXEAASA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | DGAWFEDONPXNNP-WMLDXEAASA-N |